The ASC-mediated increase of CD206, CD209, and CD163 on the surface of Mphs and mDCs suggests an enhanced ability to clear a range of blood-borne pathogens, supporting a therapeutic potential in infection-mediated diseases such as sepsis [51]. This evidence concerns the gene CD209 and infection.